PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.45%
Revenue growth of 9.45% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
8.06%
Gross profit growth of 8.06% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
14.43%
Positive EBIT growth while Healthcare median is negative. Peter Lynch might see a strong competitive advantage in operations.
17.38%
Positive operating income growth while Healthcare is negative. Peter Lynch would spot a big relative advantage here.
50.76%
Net income growth of 50.76% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
50.77%
EPS growth of 50.77% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
50.77%
Diluted EPS growth of 50.77% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.29%
Dividend growth of 35.29% while Healthcare median is flat. Walter Schloss might appreciate at least a modest improvement.
6.12%
OCF growth of 6.12% while Healthcare is zero. Walter Schloss might see a modest positive difference, which can compound over time.
6.12%
FCF growth of 6.12% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
25.67%
10Y CAGR of 25.67% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
50.38%
5Y CAGR of 50.38% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
15.60%
3Y CAGR of 15.60% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.86%
Net income/share CAGR of 64.86% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
30.47%
Net income/share CAGR of 30.47% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
4.42%
3Y net income/share CAGR of 4.42% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
134.80%
Equity/share CAGR exceeding 1.5x Healthcare median of 34.10% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
93.84%
5Y equity/share CAGR > 1.5x Healthcare median of 11.10%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
44.89%
3Y equity/share CAGR > 1.5x Healthcare median of 11.31%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
283.33%
Dividend/share CAGR of 283.33% while Healthcare is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
155.56%
5Y dividend/share CAGR of 155.56% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
91.67%
3Y dividend/share CAGR of 91.67% while Healthcare is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
32.94%
AR growth of 32.94% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
10.47%
Inventory growth of 10.47% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
11.68%
Asset growth of 11.68% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
3.71%
Positive BV/share change while Healthcare median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
187.81%
Debt growth of 187.81% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-39.78%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.